GlassScriptPhysician profile
William Bruce
NPI 1902398357
$6,048.47
in general payments reported to CMS, 2019-2025
12 companies · $17.04 in 2025
The $17.04 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.98 · 2020: $37.39 · 2022: $515 · 2023: $1,575 · 2024: $3,830 · 2025: $17.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,163 · Food and Beverage: $1,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,163.05 |
| Food and Beverage | $1,259.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prism Medical | $1,662.90 | 2024 | |
| Axogen | $1,224.67 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Arthrex, INC. | $942.70 | 2024 | |
| Skeletal Dynamics INC | $831.81 | 2023 | Ijs, Align, Geminus |
| Medartis INC. | $527.61 | 2023 | Aptus |
| Kerecis Limited | $525.27 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Depuy Synthes Sales INC. | $169.67 | 2023 | Trumatch, Xcm Biologic Tissue Matrix |
| Checkpoint Surgical, INC | $73.98 | 2019 | |
| Endo Pharmaceuticals INC. | $37.18 | 2020-2023 | Xiaflex |
| Allergan, INC. | $18.01 | 2020 | |
| Abbvie INC. | $17.63 | 2023 | Natrelle Saline-Filled Breast Implants |
| Mentor Worldwide LLC | $17.04 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bruce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.